Related Experiment Videos
[Asthma in children]
1RJ.RS@t-online.de
Insights
Early asthma diagnosis and treatment in young children are crucial to prevent irreversible lung damage. Prompt anti-inflammatory therapy, even if presumed, offers the best outcome for pediatric asthma patients.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Respiratory Medicine
Context:
- Asthma is a chronic airway inflammatory disease with reversible obstruction, often starting in early childhood.
- Current anti-inflammatory treatments (e.g., inhaled corticosteroids) are effective but patient outcomes are suboptimal.
- Challenges include late diagnosis, inappropriate treatment, and poor patient compliance, especially in children under three.
Purpose:
- To highlight the critical need for early asthma diagnosis and intervention in young children.
- To emphasize the importance of initiating long-term anti-inflammatory treatment promptly.
- To advocate for treatment strategies that minimize side effects and improve long-term lung health.
Summary:
- Asthma diagnosis in children under three is challenging but essential for preventing irreversible lung damage.
- Early and appropriate anti-inflammatory therapy is recommended as soon as asthma is confirmed or suspected.
- The goal is to initiate long-term treatment with minimal side effects to improve patient outcomes.
Impact:
- Facilitates earlier intervention in pediatric asthma, potentially reducing long-term respiratory morbidity.
- Guides clinicians towards timely and appropriate management strategies for young children with asthma.
- Emphasizes the importance of early treatment to mitigate irreversible lung damage and improve quality of life.
Abstract:
Asthma is a disease of chronic airway inflammation characterized by reversible airway obstruction often beginning in early childhood. Antiinflammatory drugs such as nedocromil, DNCG, cysteinyl leukotrienes or inhaled corticosteroids are efficient and widely recommended. Yet there is a lack between therapeutic possibilities and outcome: too many patients are treated too late, with the wrong drugs in a wrong way, and their compliance is poor. In children less than two or three years of age the diagnosis of asthma is difficult. But it is highly important to start therapy early to avoid irreversible damage of the lung. Therefore a long-term antiinflammatory treatment with the least side effects should be administered as soon as the diagnosis of asthma is confirmed or even presumed.